# Goodbody Health products included on FSA Novel Foods Register (Interview)

- Link: https://www.directorstalkinterviews.com/goodbody-health-products-included-on-fsa-novel-foods-register-interview/4121059390
- Published: 2022-04-01T07:00:52+01:00
- Author: Giles

**Goodbody Health Inc.** (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) Director
George Thomas joins DirectorsTalk Interviews to discuss the Novel Foods submission
process.

George explains the submission process, what the FSA Public list announcement means,
what it means for Goodbody and the implication this has for consumers.

Goodbody Health announced that, following the UK Food Standard Agencies (FSA) publication
of the Novel Foods approved list for CBD, the Company’s application has been approved
by the FSA to the next stage of the Novel Foods submission, being the publication
of the FSA CBD Products register. The status of ‘Awaiting Evidence’ means the FSA
are now awaiting the final toxicology results and are satisfied with all the other
evidence submitted. Once received, and if successful, the Company will progress 
to the final Validated status.

The Company welcomes this increased compliance in the sector as the new regulations
ensure that only fully compliant products are placed on the market. Those not included
on these FSA CBD products Novel Food register will have to be taken off sale. Goodbody
Health is now well placed to continue its growth in the CBD market as this process
restricts the market to fewer competitors, as many did not meet the criteria. Consumers
can visit https://ukcbdlist.com/ , a site run by the Association for the Cannabinoid
Industry (ACI), to see if a brand is compliant.

The Company’s extraction facility is HACCP, GMP and ISO 22000 certified and its 
laboratory is UKAS accredited against ISO 17025 international standard. Goodbody
Health works closely with relevant regulatory bodies (FSA, Home Office, Trading 
Standards). Goodbody Health provides CBD extraction into isolate and distillate,
manufacturing of CBD food supplements (oils, capsules, gummies, etc), cosmetics,
and has a UKAS accredited analytical laboratory testing CBD products for potency
and contaminants such as heavy metals, residual solvents, pesticides and microbials.
In managing the whole production process, the Company tests the products at every
stage of manufacturing, from extraction to the consumer product, ensuring all the
products are of the highest quality.

> Geremy Thomas, Executive Chairman, said: _“The progression so far is very welcome,
> as after a significant amount of work and investment over the last 2 years, we
> can demonstrate our ambition of best quality, best price, guaranteed. We control
> every step of the process from extraction to shelf, and test through our accredited
> laboratory, to ensure every product that is made has achieved our ‘Gold Standard’,
> demonstrating that the Company meets legal and regulatory requirements.”_

Share on:
